Forbes August 23, 2024
John Werner

Modern treatments for depression have been evolving throughout the past few decades.

In the historical context, it wasn’t long ago when hospitals were performing lobotomies on patients, but these days, that seems like the stuff of a horror film; deeply intrusive, damaging to the brain tissue, and comparatively primitive.

Since the 1940s, the common treatment became electroconvulsive therapy, which could lead to seizures and had a dramatic impact on the brain’s overall function, sometimes with deep side effects that, again, inspire a sense of terror.

Since its invention in 1985, and 2008 FDA approval for severe, or treatment resistant depression (TRD), more recently, there is a non-invasive process called Transcranial Magnetic Stimulation or TMS. In this method, Doctors place a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Medical Devices, Technology
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article